Comparing Buprenorphine and Methadone for OUD During Pregnancy
Data from the CDC suggests that 75% of overdoses in the United States involve opioids. It is abundantly clear to healthcare professionals that the rates of opioid use disorder (OUD) are rising —...How Mesenchymal Stem Cells May Reduce the Need for Antirejection Drugs
In a recent press release, Cynata Therapeutics, a biotechnology company, announced a partnership with Leiden University Medical Center (LUMC) to explore how mesenchymal stem cells may reduce the need...FDA Approves Investigational Drug Application for Bi-Functional Fusion Protein
In a recent announcement, the Simcere Pharmaceutical Group — a global pharmaceutical company with origins in China — revealed that the FDA approved its investigational new drug application...How Brain-in-a-Dish Technology Can Impact the Treatment of MDD
According to the WHO, major depressive disorder (MDD) is the most common illness, affecting approximately 280 million people worldwide. That said, treating depression presents a unique challenge for providers. With several medications...Etripamil Phase III Clinical Trials Are Successful
Milestone Pharmaceuticals recently announced positive test results from a phase III clinical trial of etripamil, a calcium channel blocker to treat paroxysmal supraventricular tachycardia (PSVT). PSVT...Understanding the Rise of Digital Pharmacies
As the world advances in the digital era, it is no surprise that more and more consumers are turning to the internet for healthcare information, advice, and even medications. While online pharmacies have been around for decades, they...How Can Remote Patient Monitoring Improve OUD Care?
Opioid use disorder (OUD) has become a very prevalent substance abuse issue. According to the CDC, approximately 75% of overdoses in 2022 involved an opioid in the United States. The pharmaceutical industry has contributed significantly to...How Digital Health Solutions Can Address Shortages in Mental Healthcare
In any given year, approximately 21 million people in the United States will experience one depressive episode. According to the National Institute of Mental Health, depression rates are most prevalent in adults between 18 and 25. Despite...Sponsored by Glooko
How Digital Companions, Therapeutics Are Changing Healthcare
Thanks to the 2020 COVID-19 pandemic, the medical industry has been hurled into a digital healthcare environment to support and provide care to patients while social distancing, leading to improved...McKesson Plans to Acquire Rx Savings Solutions
On Monday, September 19, McKesson announced that it had signed an agreement with Rx Savings Solutions. This agreement focuses on the company’s plans to acquire Rx Savings Solutions to advance the...How Biden’s Equitable Access to Research Will Impact Healthcare
On August 25, 2022, the Biden administration announced its plans to ensure equitable access to research. Outlined in the press release are the administration’s intentions to make all federally funded research free and accessible by...Sponsored by Glooko
